671 related articles for article (PubMed ID: 26864033)
21. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
[TBL] [Abstract][Full Text] [Related]
22. Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse.
Mozdzanowska K; Zharikova D; Cudic M; Otvos L; Gerhard W
Virol J; 2007 Oct; 4():118. PubMed ID: 17974006
[TBL] [Abstract][Full Text] [Related]
23. M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice.
Sarawar S; Hatta Y; Watanabe S; Dias P; Neumann G; Kawaoka Y; Bilsel P
Vaccine; 2016 Sep; 34(42):5090-5098. PubMed ID: 27595896
[TBL] [Abstract][Full Text] [Related]
24. Tissue Distribution of Memory T and B Cells in Rhesus Monkeys following Influenza A Infection.
Pichyangkul S; Yongvanitchit K; Limsalakpetch A; Kum-Arb U; Im-Erbsin R; Boonnak K; Thitithayanont A; Jongkaewwattana A; Wiboon-ut S; Mongkolsirichaikul D; Mahanonda R; Spring M; Chuang I; Mason CJ; Saunders DL
J Immunol; 2015 Nov; 195(9):4378-86. PubMed ID: 26408671
[TBL] [Abstract][Full Text] [Related]
25. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
[TBL] [Abstract][Full Text] [Related]
26. Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.
Shim BS; Choi YK; Yun CH; Lee EG; Jeon YS; Park SM; Cheon IS; Joo DH; Cho CH; Song MS; Seo SU; Byun YH; Park HJ; Poo H; Seong BL; Kim JO; Nguyen HH; Stadler K; Kim DW; Hong KJ; Czerkinsky C; Song MK
PLoS One; 2011; 6(11):e27953. PubMed ID: 22140491
[TBL] [Abstract][Full Text] [Related]
27. Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA).
Mu X; Hu K; Shen M; Kong N; Fu C; Yan W; Wei A
J Virol Methods; 2016 Feb; 228():84-90. PubMed ID: 26615805
[TBL] [Abstract][Full Text] [Related]
28. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
29. Keeping the memory of influenza viruses.
Combadière B; Sibéril S; Duffy D
Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
[TBL] [Abstract][Full Text] [Related]
30. Natural and long-lasting cellular immune responses against influenza in the M2e-immune host.
Schotsaert M; Ysenbaert T; Neyt K; Ibañez LI; Bogaert P; Schepens B; Lambrecht BN; Fiers W; Saelens X
Mucosal Immunol; 2013 Mar; 6(2):276-87. PubMed ID: 22806098
[TBL] [Abstract][Full Text] [Related]
31. Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections.
Zacharias ZR; Ross KA; Hornick EE; Goodman JT; Narasimhan B; Waldschmidt TJ; Legge KL
Front Immunol; 2018; 9():1953. PubMed ID: 30233573
[TBL] [Abstract][Full Text] [Related]
32. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
Altenburg AF; Magnusson SE; Bosman F; Stertman L; de Vries RD; Rimmelzwaan GF
Clin Exp Immunol; 2017 Oct; 190(1):19-28. PubMed ID: 28665497
[TBL] [Abstract][Full Text] [Related]
33. The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus.
Suda T; Kawano M; Nogi Y; Ohno N; Akatsuka T; Matsui M
Antiviral Res; 2011 Sep; 91(3):252-8. PubMed ID: 21722671
[TBL] [Abstract][Full Text] [Related]
34. Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.
Kim MC; Lee YN; Ko EJ; Lee JS; Kwon YM; Hwang HS; Song JM; Song BM; Lee YJ; Choi JG; Kang HM; Quan FS; Compans RW; Kang SM
Mol Ther; 2014 Jul; 22(7):1364-1374. PubMed ID: 24590045
[TBL] [Abstract][Full Text] [Related]
35. Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus.
Uddback IE; Pedersen LM; Pedersen SR; Steffensen MA; Holst PJ; Thomsen AR; Christensen JP
Sci Rep; 2016 Feb; 6():20137. PubMed ID: 26831578
[TBL] [Abstract][Full Text] [Related]
36. Predominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults.
Sridhar S; Begom S; Bermingham A; Ziegler T; Roberts KL; Barclay WS; Openshaw P; Lalvani A
Eur J Immunol; 2012 Nov; 42(11):2913-24. PubMed ID: 22777887
[TBL] [Abstract][Full Text] [Related]
37. Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies.
Schotsaert M; Ysenbaert T; Smet A; Schepens B; Vanderschaeghe D; Stegalkina S; Vogel TU; Callewaert N; Fiers W; Saelens X
Sci Rep; 2016 Apr; 6():24402. PubMed ID: 27072615
[TBL] [Abstract][Full Text] [Related]
38. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
Tsybalova LM; Stepanova LA; Kuprianov VV; Blokhina EA; Potapchuk MV; Korotkov AV; Gorshkov AN; Kasyanenko MA; Ravin NV; Kiselev OI
Vaccine; 2015 Jun; 33(29):3398-406. PubMed ID: 25976545
[TBL] [Abstract][Full Text] [Related]
39. Epitope specific T-cell responses against influenza A in a healthy population.
Savic M; Dembinski JL; Kim Y; Tunheim G; Cox RJ; Oftung F; Peters B; Mjaaland S
Immunology; 2016 Feb; 147(2):165-77. PubMed ID: 26489873
[TBL] [Abstract][Full Text] [Related]
40. Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus.
Kim MH; Kang JO; Kim JY; Jung HE; Lee HK; Chang J
Antiviral Res; 2019 Mar; 163():19-28. PubMed ID: 30639307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
